PRTA Q3 2020 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$157,000-23.4% YoY

Gross Profit

-$21M-13661.1% margin

Operating Income

-$31M-19647.1% margin

Net Income

-$31M-19475.8% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

-19.5%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$356M

Total Liabilities

$146M

Stockholders' Equity

$210M

Cash & Equivalents

$315M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$157,000	$205,000	-23.4%
Gross Profit	-$21M	-$12M	-74.6%
Operating Income	-$31M	-$21M	-47.1%
Net Income	-$31M	-$19M	-57.2%

Revenue Segments

Collaboration

$157,000100%